Condition
MET Alteration clinical trials and research
As of November 12, 2026, Find a Trial lists 2 MET Alteration clinical trials that are recruiting, at sites in 15 countries (most in France (2), Italy (2), Spain (2)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 15Countries
All recruiting trials (2)
-
Testing VERT-002 in patients with advanced solid tumors and MET alterations
This study is testing a new drug called VERT-002 to see if it can help people with advanced solid tumors that have specific changes in their genes, especially those with non-small cell lung cancer, who have run out of other treatment options.
-
Treatment of advanced solid tumors with APL-101 for specific genetic mutations
This study is testing a new oral medication called APL-101 to see if it helps people with advanced lung cancer and other solid tumors that have certain genetic changes, especially those who haven't had success with standard treatments.
Related topics
Quick answers
How many MET Alteration clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in France (2 trials), Italy (2 trials), Spain (2 trials), Taiwan (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.